Extracellular galectin-3 participates in the control of B2 lymphocyte migration and adhesion and of their differentiation into plasma cells. Here, we analyzed the role of galectin-3 in B1-cell physiology and the balance between B1a and B1b lymphocytes in the peritoneal cavity. In galectin-3 −/− mice, the total number of B1a lymphocytes was lower, while B1b lymphocyte number was higher as compared to wild-type mice. The differentiation of B1a cells into plasma cells was associated with their abnormal adhesion and location on the mesentery. The B220 and CD43, constitutively expressed by B1 lymphocytes, were respectively up-and downregulated in galectin-3 −/− mice. Mononuclear cells were strongly adhered to the mesenteric membranes of both CD43 −/− and galectin-3 −/− mice, but in contrast to CD43 −/− mice, the accumulation of B1 cells in peritoneal membranes in galectin-3 −/− mice was accompanied by their functional differentiation into plasma cells. We have shown that in the absence of galectin-3, B1-cell differentiation into plasma cells is favored and the dynamic equilibrium of B1-cell populations in the peritoneum is maintained through a compensatory increase in B1b lymphocytes.
Introduction
Myeloid and lymphoid cells of the peritoneal cavity are dispersed in peritoneal fluids and maintain close contact with the omentum and the mesenteric membranes, thus contrasting with the spatial organization of primary and secondary lymphoid organs. Both omentum and mesenteric membranes contain myeloid and lymphoid follicles, known as milky spots (Solvason et al. 1991; Pinho et al. 2002 Pinho et al. , 2005 , which are a source of cells that stand in the first line of nonspecific defense, such as macrophages and B1 lymphocytes (LeBien and Tedder 2008) . Polypoid structures originating from mesenteric milky spots were reported as sites for intense plasmacytogenesis (Weinberg et al. 1992) .
B1 lymphocytes represent a functionally distinct subset of "natural" IgM and IgA-secreting B cells that reside predominantly in pleural and peritoneal cavities and in the spleen (Martin and Kearney 2001; Baumgarth et al. 2005 . While B1a cells spontaneously secrete protective natural antibodies, B1b cells are required for long-term protection against certain parasites and bacteria (Alugupalli et al. 2004; Haas et al. 2005) .
Similar to B2 lymphocytes, B1 cells differentiate into secreting plasma cells in a Blimp-1 (B lymphocyte-induced maturation protein-1)-dependent pathway (Savitsky and Calame 2006) . In contrast to B2 cells that arise from the bone marrow throughout the life, B1 cells tend to arise early from fetal liverderived precursors and become a self-renewing cell population in the peritoneal cavity of adult mice (Hayakawa et al. 1985; Kantor and Herzenberg 1993; Marcos et al. 1994) . In adults, B1b cells are preferentially derived from bone marrow precursors described as B220 low/neg CD19 + (Montecino-Rodriguez et al. 2006) . B1 cells depend upon Blimp-1 for plasmacytogenesis, in accordance with its function of a transcription repressor acting as a master regulator of plasma cell differentiation (Fairfax et al. 2007 ), but its expression is not necessary for the formation or self-renewal of B1 lymphocytes (Savitsky and Calame 2006) .
Despite the importance of B1a-and B1b-cell populations, relatively little is known about how the cells enter, accumulate in peritoneal cavities, and drain into lymphatics through the parathymic lymph nodes (PTLN) (Ansel et al. 2002; Berberich et al. 2008) . Accumulating evidence suggests that peritoneal B1 cells traffic between milky spots and peritoneal fluid and their exit to the lamina propria is biologically regulated, either by chemokines and cytokines, such as CXCL13, CXCL-12, and IL-10 (Ansel et al. 2002; Balabanian et al. 2002; Höpken et al. 2004) or by sphingosine 1-phosphate (Kunisawa et al. 2007 ). However, the mechanisms that control the arrival of precursors from bone marrow, the first steps of B1 activation within the peritoneal cavity, and B1-cell interaction with the mesenteric membranes remain to be elucidated.
CD43, a cell surface sialoglycoprotein expressed during the stroma-dependent phase of B-cell development in bone marrow and in peritoneal B1 lymphocytes, is involved in migration of peritoneal leukocytes. It has been demonstrated that the downregulation of CD43 inhibits the egress of peritoneal leukocytes from the peritoneal cavity (Woodman et al. 1998) , and its shedding is an initial event in neutrophil migration (Lopez et al. 1998) . The role of CD43 in peritoneal B1-cell trafficking is still not clear. Intercellular adhesion molecule-1 (ICAM-1) has been identified as a putative ligand for CD43 (Ziprin et al. 2004) . Engagement of CD43 with its ligand(s) could regulate cycles of adhesion and de-adhesion, important events in B1-cell physiology. Other CD43 ligands include members of the galectin family, such as galectin-1 and galectin-3 (Yang et al. 2008) , which interact with N-acetyl-lactosamine residues found in the extracellular domain of CD43 (Hernandez et al. 2006) .
In B lymphocytes, downregulation of galectin-3 gene expression by antisense oligonucleotides led to an increase in the number of secreting plasma cells in the course of Trypanosoma cruzi infection (Acosta-Rodriguez et al. 2004) . Recently, we have observed a remarkable plasmacytogenesis in different lymphoid compartments of Schistosoma mansoni-infected galectin-3 −/− mice, as compared to infected wild-type (WT) mice (Oliveira et al. 2007 ). It was clear that the absence of galectin-3 markedly altered the program of B2 lymphocyte differentiation into plasma cells.
In the present study, we have focused on B1-cell physiology and analyzed the involvement of galectin-3 in the balance between B1a and B1b lymphocytes in the peritoneal cavity of naïve mice. In galectin-3 −/− mice, we observed a reduction in the total number of B1 cells, mainly due to the reduction in the B1a-cell subset partly compensated by a significant increase in the B1b-cell population, as compared to WT mice. Plasma cells were abnormally located and strongly adhered in the mesentery of galectin-3 −/− mice. Cell surface exposure of CD43 was decreased in B1 cells derived from galectin-3 −/− mice. We also showed that galectin-3 −/− mice are a phenocopy of CD43 −/− mice, regarding the accumulation of mononuclear cells in the mesenteric membranes. However, in contrast to the latter ones, accumulation of B1 cells on the peritoneal structures was accompanied by their functional differentiation into plasma cells in galectin-3 −/− mice. Thus, we suggest that galectin-3 interferes with B1-cell physiology at two distinct levels: regulating CD43 functions and delaying B1-cell differentiation into plasma cells in the peritoneal cavity.
Results

Dynamics and imbalance of B1 subpopulations in the peritoneal cavity of galectin-3
−/− mice Galectin-3 is involved in macrophage activation, B2 lymphocyte differentiation into plasma cells, and recruitment of inflammatory cells to peritoneal cavity. In order to investigate the role of galectin-3 in the dynamics of peritoneal B-cell populations under noninflammatory conditions, we first quantified the total number of leukocytes and B cells (CD19 + ) in peritoneal cavity of WT and galectin-3 −/− mice. Total number of leukocytes and B cells were reduced in the absence of galectin-3 (Table I) , in parallel to the reduction in non-B cells. Subsequently, we analyzed the surface expression of B220 and galectin-3 on B-cell subpopulations as well as the surface expression of galectin-3. In WT mice, B1 and B2 lymphocytes described as B220 low and B220 high respectively ( Figure 1A in R2 and R3) were positive for galectin-3. As expected, no reactivity to galectin-3 antibodies was observed in galectin-3 −/− peritoneal B cells. In galectin-3 −/− mice, we observed an intense decrease in B220 low cells ( Figure 1B , arrow) when compared to WT mice. These data suggested that the absence of galectin-3 could induce an efflux from the peritoneal cavity or a shift in B220 surface exposure from B220 low to B220 high phenotype. In order to investigate which peritoneal B-cell subpopulations (B1 or B2) were altered in the absence of galectin-3, we extended their phenotypic characterization using anti-CD19, -CD5, -Mac-1, -CD43, and -B220 antibodies. Since exposure of B220 molecule in the B1-cell surface was altered in galectin-3 −/− mice ( Figure 1B) , we selected the peritoneal B cells using the CD19 marker, within the lymphocyte region determined by FSC and SSC parameters. B1a CD19 + lymphocytes were defined as CD5
+ Mac-1 + cells, while B1b CD19 + lymphocytes were CD5 − Mac-1 + in both WT and galectin-3 −/− mice ( Figure 2A and B, in R2 and R3, respectively) . In galectin-3 −/− mice, we observed a decrease in the total B1-cell number with the reduction in B1a and increase in B1b cells, compared to WT mice (Table II) . The number of B2 lymphocytes was not modified in either WT or galectin-3 −/− mice (Table II) . Together, these results clearly demonstrated that galectin-3 interferes with peritoneal B1-cell balance without modification of B2-cell compartment.
Considering that B220 and CD43 are glycosylated molecules and are putative ligands for galectin-3, we investigated whether the absence of this lectin could modify the expression and/or cell membrane exposure of these molecules in B1a and B1b lymphocytes, defined by Mac-1 and CD5 surface markers ( Figure 2A ). Concomitantly, we found an increase in the surface expression of B220 ( Figure 2C ) and a decrease in the surface expression of CD43 ( Figure 2E ) in B1a cells from galectin-3 −/− mice. Regarding the B1b subpopulation from galectin-3 −/− mice, the exposure of B220 molecules on the cell surface was not significantly modified, although the number of B220 int cells was higher than in WT cells ( Figure 2D ). The intensity of surface CD43 was also lower in B1b cells ( Figure 2F ). The altered surface expression of both B220 and CD43 found in the absence of galectin-3 is at least a marker of the activation or differentiation state of peritoneal B1 cells.
The next step was to investigate whether the increase in the intensity of surface B220 molecules on peritoneal floating B1 cells was associated with their differentiation into plasma cells. To analyze the presence of CD138 marker separately in B1a and B1b cells, we previously sorted these populations using anti-CD19, Mac-1, and CD5 antibodies as shown in the Figure  2A and B. We observed a significant increase in B1b CD138 + cells and a moderate increase in B1a CD138
+ cells in the peritoneal cavity of galectin-3 −/− mice ( Figure 3A ), suggesting that the absence of galectin-3 increased the number of CD138 + cells indicating a possible acceleration in differentiation of B1 lymphocytes into plasma cells.
Using the same strategy in cell sorting, we evaluated the gene expression of Blimp-1 (a transcription factor involved in B1-cell secretion of immunoglobulins), IL-5 (a B1-cell-dependent growth factor), and CD43 (a glycoprotein involved in B1-cell adhesion) in B1a and B1b sorted cells. We detected a significant increase in Blimp-1 mRNA levels only in B1a cells, but not in B1b cells from galectin-3 −/− , as compared to WT mice (Figure 3B) . Although both subsets of B1 cells are IL-5R + , the IL-5 mRNA levels were significantly increased in B1b cells, but not in B1a cells from galectin-3 −/− mice ( Figure 3C ). CD43 mRNA levels were increased only in B1a cells of galectin-3 −/− mice ( Figure 3D ). Alterations observed in the gene expression profile of factors involved in B1-cell proliferation and activation suggested an active process of B1 differentiation into plasma cells within the peritoneal cavity of galectin-3 −/− mice.
Mesentery as a site for B1-cell differentiation into plasma cells in galectin-3 −/− mice
Since B1 cells were differentiating into CD138 + cells and modulating CD43 expression, we investigated the adhesion capacity of these cells on the mesenteric membranes. We performed morphological analysis of the mesentery before and after peritoneal wash procedures, in both WT and galectin-3 −/− mice. We observed that the lack of galectin-3 interfered with the distribution of B1 cells between peritoneal fluid (nonadherent or floating cells) and mesentery (adherent cells). No significant differences were observed in the adherent cell number per field in the mesenteric membranes of galectin-3 −/− mice, as compared with WT mice, before the washing procedure (Figure 4A and B; Table III , adhered cells before wash).
As the peritoneal cavity was washed, some cells were released while other cells remained adherent in the mesenteric membrane. Cellularity was significantly increased in the mesentery of galectin-3 −/− mice, as compared to WT mice (Figure 4C and D; Table III) . No adherent plasma cells were found in WT mice. Adhered plasma cells were better observed after washing, and their apparent number was increased (Table III) . This indicates that plasma cells adhered directly onto the mesenteric membranes, being partially covered by other cells. These data suggest that the absence of galectin-3 could be interfering with the adhesive properties of peritoneal cells in the mesenteric membrane. Morphological analysis of adherent cells in the mesentery revealed that in WT mice myeloid cells were the predominant cell population ( Figure 4E , arrows). In contrast, we detected adhered plasma cells frequently organized in clusters in galectin-3 −/− mice membranes ( Figure 4F , arrows). Thus, we suggested that the absence of galectin-3 induced an intense peritoneal B1-cell differentiation into plasma cells favoring their adhesive contacts with mesenteric membranes.
The absence of CD43 modifies adhesiveness of peritoneal cells onto the mesenteric membrane
In view of the cell surface decrease of CD43, a known galectin-3 ligand in lymphocytes (Stillman et al. 2006) , we monitored the involvement of this molecule on adhesion of peritoneal cells in CD43 −/− mice. In these animals, we observed adherent cells organized in large clusters in the mesentery before the peritoneal wash ( Figure 5A ) compared with the WT mice membranes under the same experimental conditions ( Figure 4A ). After the peritoneal wash procedures, we observed fewer clusters of adhered cells in CD43 −/− mice ( Figure 5B ), the myeloid cells were predominant in the mesentery and no plasma cells were found ( Figure 5C ). Interestingly, in peritoneal cells of CD43 −/− mice ( Figure 5D ), there was an increase of B220 surface molecule on B1 cells of galectin-3 −/− mice ( Figure 2C and D). Although peritoneal cells also expressed high levels of B220 molecule on the cell surface, only in the absence of galectin-3 peritoneal B1 cells completed their program of differentiation into plasma cells, with capacity to adhere onto the mesenteric membrane.
Extracellular galectin-3 modifies B220 and CD43 surface exposure on peritoneal cells
To investigate the role of exogenous galectin-3 in the control of peritoneal cell adhesion observed in vivo, we performed in vitro studies. Total peritoneal cells were plated and maintained in culture for 1 week in the supplemented medium. WT cells were predominantly spread out in culture dishes and presented a vacuolated cytoplasm ( Figure 6A ), in contrast to cells from galectin-3 −/− mice, which were predominantly highly refringent round cells ( Figure 6B ). Surface exposure of B220 and CD43 molecules ( Figure 6E and F respectively) in nonadherent cultured cells of WT and galectin-3 −/− mice was similar to the pattern observed in cells obtained ex vivo as shown in Figure 2C to F.
After the addition of an anti-galectin-3 antibody to the culture medium, the peritoneal cells of WT mice modified drastically their morphology shifting from adherent and fully spread cells to adherent round cells ( Figure 6C ) phenocopying those from galectin-3 −/− mice ( Figure 6B ). No morphological changes were observed when WT cells were treated with the isotype control antibody (Figure 6D ), compared with WT cells without any antibody addition ( Figure 6A ). Cell surface labeling of B220 and CD43 of WT peritoneal cells cultured with an anti-galectin-3 antibody ( Figure 6G and H, respectively) was equivalent to the observed in galectin-3 −/− peritoneal cultured cells ( Figure 6E  and F) . In vitro data suggested that exogenous galectin-3 has an important role in adhesion properties and differentiation of peritoneal B cell, modulating the B220 and CD43 exposure on the cell membrane.
To confirm the role of exogenous galectin-3 in the B220 and CD43 cell surface exposure, we performed in vivo experiments by inoculating both anti-galectin-3 and isotype control antibodies in the peritoneal cavity of WT mice. After 1 week, the mesenteric membranes of both treated groups were analyzed before and after peritoneal wash procedures ( Figure 7A-D) . In the mesenteric membranes treated with an anti-galectin-3 antibody, we observed a high density of adherent cells (Figure 7B ) compared with mice treated with the isotype antibody control ( Figure 7A ). However, after the peritoneal wash, we could identify mononuclear cells adhered in the mesenteric membranes from anti-galectin-3-treated WT mice ( Figure 7D ) when compared with the control group ( Figure 7C) .
To further confirm these data, we engrafted peritoneal cells from GFP transgenic mice into the peritoneal cavity of either WT or galectin-3 −/− recipient mice. After 1 week, peritoneal cells were harvested and analyzed for both B220 ( Figure 7E ) and CD43 ( Figure 7F ) cell surface expression. In Figure 7E , we observe that the B220 molecule on the cell membrane of donor GFP + cells increased when these cells were injected into the peritoneal cavity of galectin-3 −/− mice compared with GFP + cells injected in the peritoneal cavity of WT mice. The intensity of CD43 on the cell membrane ( Figure 7F ) decreased when GFP + cells were grafted into the peritoneal cavities of galectin-3 −/− mice, compared with the same cells injected within the peritoneal cavity of WT mice. Therefore, levels of B220 and CD43 molecules on the cell membranes of peritoneal cells seem to be dependent on extracellular galectin-3 from the receptor microenvironments.
Homeostasis of B-1 lymphocytes in peritoneal cavity in the absence of galectin-3
Galectin-3 regulates peritoneal B1 cells differentiating into plasma cells. In spite of the imbalance between B1a and B1b inside of peritoneal cavity, B-cell homeostasis was apparently maintained and intrinsically regulated. It was reported recently that Lin neg CD19 + B220 −/low bone marrow precursor cells were able to repopulate preferentially B1b peritoneal cells of irradiated adult mice (Montecino-Rodriguez et al. 2006 ). Here, we investigated whether the absence of galectin-3 would modify the distribution of these cells in bone marrow and peripheral blood. In bone marrow of WT mice ( Figure 8A ), these cells represented approximately 0.4% of total bone marrow cells. In contrast, in galectin-3 −/− mice we observed a 3-fold increase in the population of Lin neg CD19 + B220 −/low cells within the bone marrow ( Figure 8B ). An increase in Lin neg CD19 + B220
−/low cells was also observed in the peripheral blood in galectin-3 −/− mice ( Figure 8D ), when compared with the WT mice ( Figure 8C) .
Considering that the blood flow transports cells to tissues, we investigated the presence of B cells inside the peritoneal cavity. In galectin-3 −/− mice, we observed an increased proportion of circulating CD19 + B220 neg/low cells ( Figure 8D ). In the peritoneal cavity of these mice, an increased proportion of 
cells displaying a CD19
+ B220 int/high phenotype were observed ( Figure 8F , in R2). This stands in contrast with the phenotype of cells found in the peritoneal cavity of WT mice, whose phenotype was CD19 + B220 low/int ( Figure 8E , in R2). No modifications were observed in CD19 + B220 high cells, described as B2 lymphocytes in both WT and galectin-3 −/− mice ( Figure 8E and F, in R3, respectively). Our results suggest that the absence of galectin-3 in the peritoneal microenvironment induced the increase in B220 exposure on the cell surface, favoring the differentiation process that is being compensated by cells F L Oliveira et al. Fig. 8 . Analysis of Lin neg CD19 + B220 neg/low cells in bone marrow, peripheral blood, and peritoneal cavity. Lin neg CD19 + B220 neg/low bone marrow cells in WT and galectin-3 −/− mice (A and B selected region, respectively). These cells were found in the blood of WT (C, selected region) and increased in galectin-3 −/− mice (D, selected region). (E) In the peritoneal cavity of WT mice, the CD19 +/high B220 neg/low cells represent B1 cells while the CD19 +/low B220 high represent B2 cells in WT mice (E, selected in R2 and R3, respectively). (F) In galectin-3 −/− mice, the CD19 +/high B220 neg/low cells were shifted to CD19 +/high B220 low/int phenotype (selected in R2) while the CD19 +/low B220 high cells were not modified (selected in R3). Data are representative of three independent experiments, each one carried out in five WT and galectin-3 −/− mice.
arriving from the bone marrow compartment via peripheral blood.
Discussion
Our results demonstrated that the absence of galectin-3 modifies the homeostasis of B1 lymphocytes in the peritoneal cavity, by accelerating their differentiation into plasma cells. The accelerated program in cell differentiation is suggested by upregulation of cell surface B220 and downregulation of CD43 exposure associated with a high level of Blimp-1 mRNA. Here, we suggest a new function of galectin-3 in the regulation of differentiation of B1 lymphocytes into plasma cells.
The absence of galectin-3 clearly promoted a decrease in the number of total leukocytes and B cells (CD19 + cells) inside the peritoneal cavity, under a noninflammatory condition. Considering that B1 lymphocytes are resident cells, these data suggested that the intense efflux of cells from peritoneal cavity and/or a phenotypic alteration in B220 surface expression are the major mechanisms involved. However, we should consider as a potential complementary mechanism a reduced influx of the leukocytes moving into the peritoneal cavity, as clearly demonstrated in models of acute peritonitis (Colnot et al. 1998; Hsu et al. 2000) and in pulmonary infections caused by Streptococcus pneumoniae (Nieminen et al. 2008) .
According to the literature, both B1 and B2 lymphocytes require Blimp-1 to differentiate into secretory plasma cells (Savitsky and Calame 2006) . It has been demonstrated that in splenic B2 lymphocytes, a high level of Blimp-1 is a sine qua non condition for rapid secretion of immunoglobulins (AngelinDuclos et al. 2000; Lin et al. 2002) . In the peritoneal cavity, B1a lymphocytes respond more promptly than B1b to several stimuli, by secreting mainly the natural IgM antibodies. The difference in their capacity of response could be attributed to the differential expression of Blimp-1 in both subpopulations as observed in the present work. CD138 + B1b cells are increased in the peritoneal wash, but without the concomitant increase in the Blimp-1 expression as observed in CD138 + B1a cells. It means probably that B1b cells are not completing their program of differentiation into plasma cells with the same frequency observed in B1a cells. Our results suggest that B1a cells respond more promptly than B1b due to the higher expression of Blimp-1 mRNA in the absence of galectin-3.
The concomitant absence of galectin-3 with a high level of Blimp-1 has been demonstrated also in splenic B2 lymphocytes activated by T. cruzi infection (Acosta- Rodriguez et al. 2004 ). These authors have also suggested that galectin-3 favors the memory B2 cell fate. In addition, we have previously described high levels of IgG and IgE antibodies in the sera of galectin-3 −/− noninfected mice without modifications in the IgM levels (Oliveira et al. 2007) . Here, we further demonstrated that the complete absence of galectin-3 in naive knockout mice modifies the Blimp-1 level on B1 lymphocytes, which is associated with their high degree of differentiation into plasmablasts (CD138 low ) and plasma cells inside of peritoneal cavity and in the mesentery, respectively. Recently, Tsai et al. (2008) showed that Blimp-1 induces transcription of galectin-1 that, once secreted, favors the differentiation of antibody secreting plasma cells. Extracellular galectin-1 and -3 therefore play opposing roles in B-cell differentiation. The underlying mechanisms for the antagonism of these lectins are not known. As they may interact with similar ligands on the cell surface, such as CD43 and CD45 isoforms (e.g., B220), antagonism could be either competitive or potentially dependent upon the activation of different signaling pathways.
Under physiological conditions, B1 lymphocytes exit from the peritoneal cavity constitutively and their differentiation program includes the increase in cell surface B220 and CD43 molecules, which are critically involved in cell activation and migration, respectively (Foussat et al. 2001 ). B1 lymphocytes do not differentiate directly into plasma cells in the peritoneal cavity, and they have to migrate into the intestinal lamina propria where they complete their differentiation program and switch from IgM to IgA-secreting cells (Beagley et al. 1995; Kroese and Bos 1999 ). In our model, the absence of galectin-3 in B1 lymphocytes resulted in the upregulation of B220 on the cell surface, concomitantly with the decreased expression or exposure of CD43 on the cell surface, thus altering cell adhesion and de-adhesion properties.
In the absence of galectin-3, B1 cells displaying low levels of CD43 remained adhered onto the mesenteric membranes, where they differentiated into plasma cells. Accordingly, most peritoneal cells in CD43 −/− mice were adhered on the mesentery, but without any evidence of plasma cell generation. These data indicate that only the absence of the CD43 is not sufficient to induce B1-cell differentiation into plasma cells, although the surface exposure of B220 was upregulated. Galectin-3 seems to control negatively the B1a differentiation program into plasma cells, and this program involves the control of the Blimp-1 pathway, which in turn controls the Ig secretory pathway.
Interestingly, both surface proteins B220 and CD43 are heavily glycosylated in the extracellular domain suggesting that they are possible ligands for galectin-3. B220 (CD45RA) is expressed on the cell membrane during all steps of B-cell differentiation and activation, and it is considered to be an essential regulatory molecule in the BCR signaling pathway (Coffman and Weissman 1981; Huntington and Tarlinton 2004) . In addition, surface CD43 is expressed concomitantly with B220 molecules in a very early stage of B-cell development and expressed de novo by peritoneal B1 cells, but not by mature B2 lymphocytes. In B2-cell development, upregulation of B220 is accompanied by a downregulation of CD43, which is expressed only in pre-B lymphocytes. High levels of B220 in peripheral B2 cells could explain in part the absence of CD43 on their surface. In this context, low levels of B220 on the surface of B1 cells could be associated with the presence of CD43, mimicking the early steps of bone marrow development (Hardy and Hayakawa 2001) . Accordingly, B220-cell surface expression was higher in B cells from CD43 knockout animals. In the absence of galectin-3, B220 molecules were highly expressed on the surface of B1 cells. Under this condition, B1-cell differentiation was altered. Reciprocal loss of CD43 on the cell surface leads to deregulation of the adhesion and deadhesion properties of these cells (McEvoy et al. 1997; Matsumoto et al. 2008) . Our results add new information about these two molecules in the control of the B1-cell behavior within the peritoneal cavity and their interaction with mesenteric membranes.
It has been demonstrated that peritoneal mononuclear cells of galectin-3 −/− mice presented a delay in their capacity to differentiate into macrophages in vitro (Colnot et al. 1998; Hsu et al. 2000) . The same results were obtained recently by our group, in cultures of mononuclear cells from hepatic granulomatous inflammatory reactions, indicating that the absence of galectin-3 modifies monocyte activation in vivo and in vitro, besides altering the pattern of collagen deposition around the S. mansoni eggs (Oliveira et al. 2007 ). According to in vitro data of this work, we can suggest that signals controlling peritoneal cell adherence and activation are dependent on the extracellular galectin-3. As we observed, the addition of soluble anti-galectin-3 antibodies in the culture system altered the pattern of cell adherence and activation by modifying the surface expression of CD43 and B220, similarly to that observed in galectin-3 −/− mice. The hypothesis that extracellular galectin-3 could be responsible for regulation of peritoneal cell differentiation is reinforced by our experiments using GFP-peritoneal cell grafting. Similar to the in vitro assays, the phenotype of WT/GFP + cells was drastically modified upon transplantation into peritoneal cavity of galectin-3 −/− mice, suggesting that the surface galectin-3 signaling is constitutive and necessary for controlling adherence and activation of peritoneal cells, mainly B1 lymphocytes. Differentiation of B1 lymphocytes into plasma cells in the mesentery increases the demand for new cells to maintain the cellular equilibrium between B1 subpopulations in loco. Our results suggest that the numerical differences between B1a and B1b cells can be explained by the anatomical localization of their precursors. B1a cells are produced earlier in the ontogeny and are maintained by self-renewal in the peritoneal cavity. In contrast, B1b cells are maintained by progenitors in the bone marrow, described recently by Montecino-Rodriguez (2006) as being CD19
+ /B220 low/neg lymphocytes. In galectin-3 −/− mice, we monitored the presence of these CD19 + /B220 low/neg cells in bone marrow, bloodstream, and peritoneal cavity. Our results suggest that the increased plasmacytogenesis within the peritoneal cavity could stimulate the recruitment of new B1 lymphocytes. As B1a self-renewing cells may differentiate rapidly and adult bone marrow is capable of repopulating mainly B1b cells, this subpopulation predominates among peritoneal B1 cells.
In the present study, we did not analyze B1a splenic lymphocytes, although it has been demonstrated that the spleen is required for generation and maintenance of these cells (Wardemann et al. 2003) . On the other hand, B1a cells resident in the spleen seem to respond promptly to systemic bacterial stimuli, such as LPS, and differentiate into plasma cells immediately, and that additional B1a cells emigrate from the peritoneal cavity, thus replenishing continuously this reservoir and contributing to the first step of the innate immune response (Yang et al. 2007) .
Here, we showed that homeostasis of the B1 pool from peritoneal cavity is controlled locally by the mesenteric microenvironment and systemically by the bone marrow compartment, which replenishes B1b subpopulation. In the absence of galectin-3, mesenteric membranes are a more adhesive substratum for mononuclear cells, favoring differentiation of galectin-3-deficient B1a cells into plasma cells. Increased adhesiveness depends, at least in part, on loss of the galectin-3 ligand CD43 from the cell surface. Although necessary, increased adhesion is not sufficient for plasma cell differentiation, as observed in CD43 −/− mice. Therefore, galectin-3 interferes with two distinct processes involved with plasmacytogenesis of peritoneal B1 cells, as it decreases CD43 exposure on the cell surface and it is a negative regulator of Blimp-1 expression on B1a cells. The mechanisms underlying Blimp-1 control by galectin-3 warrants further investigation.
Material and methods
Mice
Inbred wild-type (WT) C57/bl6 mice, Gal-3 −/− mice (Hsu et al. 2000) , GFP transgenic mice (Okabe et al. 1997) , and CD43 −/− mice (Manjunath et al. 1995) , age and sex matched, were obtained from the colony bred at the Federal University of Rio de Janeiro (Brazil). All the cells from GFP transgenic mice express GFP. Mice manipulations were performed in accordance with institutional guidelines (protocol DAHEICB 009, Federal University of Rio de Janeiro).
Bone marrow, blood and peritoneal cells, and mesentery analysis
Peritoneal, blood, and bone marrow cell suspensions were harvested on cold phosphate-buffered saline (PBS), pH 7.2, with 3% fetal bovine serum (FBS). Red blood cells were lysed with the hypotonic ACK solution. After lysis of red cells, cell suspensions were washed twice with PBS and cell density was adjusted to 10 6 cells/mL. The mesentery was obtained before and after the peritoneal wash. The peritoneal cavity was opened, and mesentery was cut out and fully stretched on glass slides. Subsequently, membranes were fixed in absolute methanol during 24 h. For analysis of the mesenteric membranes before the peritoneal wash, the peritoneal cavity was not emptied and the peritoneal cells remained attached to the mesentery. When the mesentery was obtained after the peritoneal wash, nonadherent cells and loosely attached cells were collected during the washing and used for the phenotypic analysis and cell sorting procedures. Strongly adherent cells remained attached to the mesentery and were examined after the peritoneal wash. Mesenteries were stained by MayGrünwald & Giemsa's method and analyzed under an optical microscope (Zeiss-Axioplan, Jena, Germany) as described elsewhere (El-Cheikh and Borojevic 1990). The images were acquired in the bright field using a camera Evolution MP 5.0 RTV-Color-Media Cybernetics, Canada.
Flow cytometry
In order to saturate Fc receptors, all cells were incubated with the Fc blocker antibody (clone 2.4G2) for 10 min before adding specific monoclonal antibodies (mAbs). Cells were incubated with mAbs for 30 min; unbound mAbs were washed out with PBS. The following mAbs were used: FITC-labeled B220 and CD43; PE-labeled Mac-1, CD19, CD138, and CD43; biotin-labeled B220 developed with streptavidin-APC; and Cychrome-labeled CD5 (all from BD Bioscience, San José, CA). The unlabeled anti-galectin-3 was obtained from the M3/38 hybridoma (ATCC, Manassas, VA USA). PE-labeled cell lineage markers included the following antibodies: anti-Ter-119, -Gr-1, -Mac-1, -CD4 and -CD8, which were used to exclude differentiated cells (Lin neg cells) in the bone marrow, except B-cell lineage. The secondary antibody was an FITC-labeled anti-rat IgG. Samples were acquired in a flow cytometer (FACScalibur, BD Bioscience, San Jose, CA) and analyzed using two specific softwares: Cell Quest and WinMDI 2.8.
Cells in mesenteric membranes
Mesenteric membranes from WT and gal-3 −/− mice were stained with May-Grünwald & Giemsa stains and the cellularity was determined using optical microscopy (Olympus Optical BX51TF, Japan). Microscopic analysis was performed with 1000× magnification and the cells were quantified in 20 fields randomly. The data represent five animals per group and the means were established using GraphPad Prism TM software. Mesenteric plasma cells were quantified using Image J (a public domain Java image processing program inspired by NIH Image for the Macintosh, Research Services Branch, National Institute of Mental Health, Bethesda, MD), according to conventional plasma cell morphological characteristics.
In vivo experiments
In vivo cell transfer experiments were done by intraperitoneal injection of peritoneal cells from GFP transgenic mice (10 6 cells/200 μL PBS) into either WT or gal-3 −/− mice peritoneal cavity. The GFP + cells were maintained in the peritoneal microenvironment for 7 days, and harvested for phenotypic analyses. The intra-peritoneal injection of anti-galectin-3 mAB (clone M3/38) or isotype control IgG2a was performed in a single dose (approximately 0.5 mg/200 μL per mouse). Seven days after treatment, the mice were euthanized with CO 2 . Peritoneal cells were harvested and stained for phenotypic analysis by flow cytometry.
In vitro assays A total of 5.0 × 10 5 peritoneal cells from WT or galectin-3 −/− mice were harvested in Modified Eagle's medium (alfa-MEM) supplemented with 10% FBS, 2 mM glutamine, 10 −5 β-mercaptoethanol, and 100 mg/mL penicillin and streptomycin and cultured in 25 cm 2 tissue culture flasks during a week at 37
• C in 5% CO 2 . Concomitantly, anti-galectin-3 mAb or isotype antibody controls were added in the culture. No feeder layer cells nor cytokines were added into these cultures. Phenotypic analyses were performed after 1 week.
Peritoneal cell sorting
Peritoneal B1a and B1b cells from WT and Gal-3 −/− mice were sorted based on CD19, CD5, and Mac-1 expression. B1a cells were sorted as CD19 + CD5 + Mac-1 + cells and B1b cells as CD19
+ CD5 − Mac-1 + cells using a MoFlo cytometer (DakoCytomation, Denmark). Both fractions were harvested in RPMI 1640 supplemented with 10% FBS. Post-sort analysis using Summit v4.3 software showed purities of >90% for both subsets (data not shown). Subsequently, peritoneal subpopulations were centrifuged at 1200 rpm and the pellet was suspended in 1 mL Trizol for real-time RT-PCR experiments.
Real-time quantitative PCR analysis
Total RNA was isolated from 10 6 cells using the TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA), following the manufacturer's instructions. cDNA synthesis was performed in a final volume of 20 μL, using ImProm-II reverse transcriptase (Promega Corporation, Madison, WI). The reaction mixture contained 4 μg total RNA, 20 pmol oligo dT primer (Invitrogen Life Technologies), 40 U RNasin, 500 μM of dNTP mix, and 1 U reverse transcriptase in the 1× reverse transcriptase buffer. The cDNA was treated with 10 μg RNase (Gibco, Carlsbad, CA) and then immediately used or stored at −20
• C. PCR amplification and analysis were done using an ABI Prism 7500 sequence detector (Applied Biosystems, Foster City, CA). All the reactions were done with SYBR Green Master Mix (Applied Biosystems) using a 25 μL volume in each reaction, which contained 2 μL template cDNA, 5 pmol each primer, and 12.5 μL SYBR Green. The primers used for PCR amplification were β-actin (forward: 5 -AGCTGCGTTTTACACCCTTT-3 , reverse: 5 -AAGCCATGCCAATGTTGTCT-3 ); Blimp-1 (forward: 5 -AAGTCTAGCTCCGGCTCCGT-3 , reverse: 5 -TCGGCCTCT GTCCACAAAGT-3 ); IL-5 (forward: 5 -AGACGGAGGACG
